Millipore Sigma Vibrant Logo

437725 Lipoxin A₄, 15-epi - CAS 171030-11-8 - Calbiochem

Lipoxin A₄, 15-epi, CAS 171030-11-8, is an epimeric lipoxin A4 (Cat. No. 437720) analog that is more potent and metabolically stable than LXA4.

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: LXA₄-15-epi, 15(R)-LXA₄, Aspirin-triggered LXA₄, (5S,6R,15R)-5,6,15-Trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid

View Products on Sigmaaldrich.com
437725
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
171030-11-8C₂₀H₃₂O₅

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
437725-25UG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Glasflasche 25 μg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewA epimeric lipoxin A4 (Cat. No. 437720) analog that is more potent and metabolically stable than LXA4. Exhibits anti-inflammatory properties and serves as a "stop signal" to excessive leukocyte trafficking/infiltration. Blocks TNF-α-induced IL-8 release in human enterocyte. It is also an important modulator of the many pharmacological actions caused by aspirin.
      Caution! Product contains volatile liquid. Keep product cold at all times.
      Catalogue Number437725
      Brand Family Calbiochem®
      SynonymsLXA₄-15-epi, 15(R)-LXA₄, Aspirin-triggered LXA₄, (5S,6R,15R)-5,6,15-Trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid
      References
      ReferencesWallace, J.L., and Fiorucci, S. 2003. Trends Pharmacol. Sci. 24, 323.
      Filep, J.G., et al. 2002. Adv. Exp. Med. Biol. 507, 223.
      Titos, E., et al. 1999. Am. J. Physiol. 277, C870.
      Gronert, K., et al. 1998. J. Exp. Med. 187, 1285.
      Maddox, J.F., et al. 1997. J. Biol. Chem. 272, 6972.
      Claria, J., et al. 1996. Mol. Med. 2, 583.
      Claria, J., and Serhan, C.N. 1995. Proc. Natl. Acad. Sci. USA 92, 9475.
      Serhan, C.N., et al. 1995. Biochemistry 34, 14609.
      Product Information
      CAS number171030-11-8
      ATP CompetitiveN
      FormLiquid
      FormulationIn Ethanol.
      Hill FormulaC₂₀H₃₂O₅
      Chemical formulaC₂₀H₃₂O₅
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetExhibits anti-inflammatory properties
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Flammable
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage ≤ -70°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw aliquot and freeze (-70°C).
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      437725-25UG 04055977186895

      Documentation

      Lipoxin A₄, 15-epi - CAS 171030-11-8 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Lipoxin A₄, 15-epi - CAS 171030-11-8 - Calbiochem Analysenzertifikate

      TitelChargennummer
      437725

      Literatur

      Übersicht
      Wallace, J.L., and Fiorucci, S. 2003. Trends Pharmacol. Sci. 24, 323.
      Filep, J.G., et al. 2002. Adv. Exp. Med. Biol. 507, 223.
      Titos, E., et al. 1999. Am. J. Physiol. 277, C870.
      Gronert, K., et al. 1998. J. Exp. Med. 187, 1285.
      Maddox, J.F., et al. 1997. J. Biol. Chem. 272, 6972.
      Claria, J., et al. 1996. Mol. Med. 2, 583.
      Claria, J., and Serhan, C.N. 1995. Proc. Natl. Acad. Sci. USA 92, 9475.
      Serhan, C.N., et al. 1995. Biochemistry 34, 14609.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision06-August-2008 RFH
      SynonymsLXA₄-15-epi, 15(R)-LXA₄, Aspirin-triggered LXA₄, (5S,6R,15R)-5,6,15-Trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid
      DescriptionAn epimeric lipoxin A4 (Cat. No. 437720) analog that is more potent and metabolically stable than LXA4. Exhibits anti-inflammatory properties and serves as a "stop signal" to excessive leukocyte trafficking/infiltration. Reported to block TNF-α-induced IL-8 release in human enterocytes. Also reported to be an important modulator of the pharmacological actions of aspirin.

      Caution! Product contains volatile liquid; keep cold at all times.
      FormLiquid
      FormulationIn Ethanol.
      Intert gas (Yes/No) Packaged under inert gas
      CAS number171030-11-8
      Chemical formulaC₂₀H₃₂O₅
      Structure formulaStructure formula
      Purity≥98% by HPLC
      Storage Protect from light
      ≤ -70°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw aliquot and freeze (-70°C).
      Toxicity Flammable
      ReferencesWallace, J.L., and Fiorucci, S. 2003. Trends Pharmacol. Sci. 24, 323.
      Filep, J.G., et al. 2002. Adv. Exp. Med. Biol. 507, 223.
      Titos, E., et al. 1999. Am. J. Physiol. 277, C870.
      Gronert, K., et al. 1998. J. Exp. Med. 187, 1285.
      Maddox, J.F., et al. 1997. J. Biol. Chem. 272, 6972.
      Claria, J., et al. 1996. Mol. Med. 2, 583.
      Claria, J., and Serhan, C.N. 1995. Proc. Natl. Acad. Sci. USA 92, 9475.
      Serhan, C.N., et al. 1995. Biochemistry 34, 14609.